Drug Type Antibody drug conjugate (ADC) |
Synonyms AntiGD2RLI OGD2 Pharma, ICK IL15 OGD2 Pharma, OGD 202 + [1] |
Target |
Action inhibitors, stimulants |
Mechanism GD2 inhibitors(Disialoganglioside GD2 inhibitors), Immunostimulants, Natural killer cells stimulants(Natural killer cells stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | France | - |